Pricing Log in Create free account
Tuesday 13 October 2026 Export CNC’s income statement to Excel — free account

Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Centene Corporation (CNC) SEC filings, changes and red flags

Red flags

  • Officer departure

    Centene Corporation reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Impairment

    Centene Corporation recorded a goodwill impairment of $6.7 billion in fiscal Q3 2025

    10-Q filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Oct 8, 2026 8.01 Other events
8-K Sep 16, 2026 7.01 Regulation FD disclosure
8-K Aug 12, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Jul 29, 2026 8.01 Other events
8-K Jul 28, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 26 added · 5 removed · 27 modified
P2I1A: no material changes, the filing says
8-K Jun 19, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 12, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders
8-K Apr 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Mar 18, 2026 5.02 Departure or appointment of directors or officers
8-K Mar 10, 2026 7.01 Regulation FD disclosure; 8.01 Other events
8-K Feb 23, 2026 7.01 Regulation FD disclosure
10-K Dec 31, 2025 1: 22 added · 12 removed · 46 modified
1A: 9 added · 5 removed · 38 modified
7: 47 added · 36 removed · 58 modified
8-K Feb 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 10, 2025 7.01 Regulation FD disclosure
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 Impairment
8-K Sep 11, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.